LifeStance Health Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	1,368	1,251	1,056	859.54	667.51	377.22
Revenue Growth (YoY)	13.39%	18.50%	22.82%	28.77%	76.96%	77.50%
Cost of Revenue	923.33	848.57	753.57	622.53	466	242.9
Gross Profit	444.24	402.4	302.1	237.02	201.51	134.32
Selling, General & Admin	379.49	360.32	343.27	373.43	431.13	87.84
Operating Expenses	435.48	431.27	423.7	442.63	485.26	118.88
Operating Income	8.76	-28.87	-121.61	-205.61	-283.76	15.44
Interest Expense	-18.18	-26.54	-21.22	-19.93	-38.91	-22.13
Other Non Operating Income (Expenses)	-0.4	-0.36	-0.11	-0.22	-0.26	-0.28
EBT Excluding Unusual Items	-9.82	-55.77	-142.94	-225.75	-322.92	-6.97
Merger & Restructuring Charges	-1.23	-1.91	-15.69	-3.05	-6.07	-37.18
Legal Settlements	-1.63	-1.59	-51.03	-0.85	-	-
Other Unusual Items	0.97	1.65	3.08	-3.08	-4.12	-0.25
Pretax Income	-11.72	-57.61	-206.58	-232.73	-333.11	-44.41
Income Tax Expense	-2.6	-0.17	-20.32	-17.17	-25.91	-6.34
Net Income	-9.12	-57.44	-186.26	-215.56	-307.2	-38.07
Preferred Dividends & Other Adjustments	-	-	-	-	36.75	248.3
Net Income to Common	-9.12	-57.44	-186.26	-215.56	-343.95	-286.37
Shares Outstanding (Basic)	384	379	367	355	328	302
Shares Outstanding (Diluted)	384	379	367	355	328	302
Shares Change (YoY)	1.87%	3.18%	3.43%	8.47%	8.33%	999949.62%
EPS (Basic)	-0.02	-0.15	-0.51	-0.61	-1.05	-0.95
EPS (Diluted)	-0.03	-0.15	-0.51	-0.61	-1.05	-0.95
Free Cash Flow	119.39	85.69	-57.4	-26.47	-85.07	-46.6
Free Cash Flow Per Share	0.31	0.23	-0.16	-0.07	-0.26	-0.15
Gross Margin	32.48%	32.17%	28.62%	27.57%	30.19%	35.61%
Operating Margin	0.64%	-2.31%	-11.52%	-23.92%	-42.51%	4.09%
Profit Margin	-0.67%	-4.59%	-17.64%	-25.08%	-51.53%	-75.92%
Free Cash Flow Margin	8.73%	6.85%	-5.44%	-3.08%	-12.75%	-12.35%
EBITDA	64.75	42.08	-41.17	-136.41	-229.62	46.48
EBITDA Margin	4.74%	3.36%	-3.90%	-15.87%	-34.40%	12.32%
D&A For EBITDA	55.99	70.95	80.44	69.2	54.14	31.05
EBIT	8.76	-28.87	-121.61	-205.61	-283.76	15.44
EBIT Margin	0.64%	-2.31%	-11.52%	-23.92%	-42.51%	4.09%
Advertising Expenses	-	12.57	9.4	8.63	-	-

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q